ONCT - Oncternal Therapeutics Inc. (ONCT) CEO Dr. Jim Breitmeyer on Q1 2020 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT)
Q1 2020 Earnings Conference Call
May 7, 2020, 05:00 PM ET
Company Participants
Richard Vincent - CFO
Jim Breitmeyer - President and CEO
Frank Hsu - Chief Medical Officer
Conference Call Participants
Hartaj Singh - Oppenheimer
Carl Byrnes - Northland Securities
Robert Burns - H.C. Wainwright
Presentation
Operator
Greetings, and welcome to the Oncternal Therapeutics Incorporated First Quarter Financial Results Conference Call.
At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.